Cargando…

The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis

BACKGROUND: Studies on stroke and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) have produced conflicting results. OBJECTIVE: The aim of the study was to assess the associations of Lp-PLA(2) levels (mass and activity) with recurrent vascular events in patients with transient ischemic attack...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ye, Jia, Huan, Li, Sichen, Wu, Yanmin, Guo, Li, Tan, Guojun, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758266/
https://www.ncbi.nlm.nih.gov/pubmed/29390564
http://dx.doi.org/10.1097/MD.0000000000009413
_version_ 1783290978687254528
author Tian, Ye
Jia, Huan
Li, Sichen
Wu, Yanmin
Guo, Li
Tan, Guojun
Li, Bin
author_facet Tian, Ye
Jia, Huan
Li, Sichen
Wu, Yanmin
Guo, Li
Tan, Guojun
Li, Bin
author_sort Tian, Ye
collection PubMed
description BACKGROUND: Studies on stroke and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) have produced conflicting results. OBJECTIVE: The aim of the study was to assess the associations of Lp-PLA(2) levels (mass and activity) with recurrent vascular events in patients with transient ischemic attack (TIA) and/or first ischemic stroke and with stroke in the general population. METHODS: The MEDLINE, Embase, the Cochrane Library, Web of Science, Science Direct, China National Knowledge Infrastructure, China Biology Medical Disc (CBMdisc), and WanFang were searched for prospective observational studies reported until January 2017. Eligible studies reported Lp-PLA2 levels and adjusted risk estimates of recurrent vascular events and/or stroke. Risk ratio (RR) with corresponding 95% confidence intervals (CIs) were used to express the pooled data in a random-effects model. RESULTS: A total of 11 studies that comprised 20,284 participants (4,045 were TIA and/or first ischemic stroke patients and 16,239 were residents in general population) were identified, which reported either Lp-PLA(2) mass levels (4 studies) or Lp-PLA(2) activity levels (10 studies). The pooled RR of recurrent vascular events (467 cases) in TIA and/or first ischemic group was 2.24 (95% CI, 1.33–3.78), whereas the pooled RR of stroke (1604 cases) in the general population was 1.47 (95% CI, 1.10–1.97). The pooled RRs of Lp-PLA(2) mass and activity levels with the risk of stroke in the general population were 1.69 (95% CI, 1.03–2.79) and 1.28 (95% CI, 0.88–1.85), respectively. CONCLUSIONS: In patients with TIA and first ischemic stroke, elevated Lp-PLA2 activity levels were associated with recurrent vascular events. And in the general population elevated Lp-PLA2 levels were associated with the risk of stroke, although the association between Lp-PLA(2) activity levels and the risk of stroke was less profound compared with the corresponding association of stroke risk with the Lp-PLA(2) mass levels.
format Online
Article
Text
id pubmed-5758266
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-57582662018-01-29 The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis Tian, Ye Jia, Huan Li, Sichen Wu, Yanmin Guo, Li Tan, Guojun Li, Bin Medicine (Baltimore) 5300 BACKGROUND: Studies on stroke and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) have produced conflicting results. OBJECTIVE: The aim of the study was to assess the associations of Lp-PLA(2) levels (mass and activity) with recurrent vascular events in patients with transient ischemic attack (TIA) and/or first ischemic stroke and with stroke in the general population. METHODS: The MEDLINE, Embase, the Cochrane Library, Web of Science, Science Direct, China National Knowledge Infrastructure, China Biology Medical Disc (CBMdisc), and WanFang were searched for prospective observational studies reported until January 2017. Eligible studies reported Lp-PLA2 levels and adjusted risk estimates of recurrent vascular events and/or stroke. Risk ratio (RR) with corresponding 95% confidence intervals (CIs) were used to express the pooled data in a random-effects model. RESULTS: A total of 11 studies that comprised 20,284 participants (4,045 were TIA and/or first ischemic stroke patients and 16,239 were residents in general population) were identified, which reported either Lp-PLA(2) mass levels (4 studies) or Lp-PLA(2) activity levels (10 studies). The pooled RR of recurrent vascular events (467 cases) in TIA and/or first ischemic group was 2.24 (95% CI, 1.33–3.78), whereas the pooled RR of stroke (1604 cases) in the general population was 1.47 (95% CI, 1.10–1.97). The pooled RRs of Lp-PLA(2) mass and activity levels with the risk of stroke in the general population were 1.69 (95% CI, 1.03–2.79) and 1.28 (95% CI, 0.88–1.85), respectively. CONCLUSIONS: In patients with TIA and first ischemic stroke, elevated Lp-PLA2 activity levels were associated with recurrent vascular events. And in the general population elevated Lp-PLA2 levels were associated with the risk of stroke, although the association between Lp-PLA(2) activity levels and the risk of stroke was less profound compared with the corresponding association of stroke risk with the Lp-PLA(2) mass levels. Wolters Kluwer Health 2017-12-22 /pmc/articles/PMC5758266/ /pubmed/29390564 http://dx.doi.org/10.1097/MD.0000000000009413 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5300
Tian, Ye
Jia, Huan
Li, Sichen
Wu, Yanmin
Guo, Li
Tan, Guojun
Li, Bin
The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
title The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
title_full The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
title_fullStr The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
title_full_unstemmed The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
title_short The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
title_sort associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with lipoprotein-associated phospholipase a(2): a systematic review and meta-analysis
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758266/
https://www.ncbi.nlm.nih.gov/pubmed/29390564
http://dx.doi.org/10.1097/MD.0000000000009413
work_keys_str_mv AT tianye theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT jiahuan theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT lisichen theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT wuyanmin theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT guoli theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT tanguojun theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT libin theassociationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT tianye associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT jiahuan associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT lisichen associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT wuyanmin associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT guoli associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT tanguojun associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis
AT libin associationsofstroketransientischemicattackandorstrokerelatedrecurrentvasculareventswithlipoproteinassociatedphospholipasea2asystematicreviewandmetaanalysis